Search

Codexis Inc

Закрыт

СекторЗдравоохранение

1.35 2.27

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.3

Макс.

1.3900000000000001

Ключевые показатели

By Trading Economics

Доход

-3.3M

-12M

Продажи

-333K

15M

Прибыль на акцию

-0.13

Рентабельность продаж

-80.489

Сотрудники

146

EBITDA

-4.3M

-11M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+430.3% upside

Дивиденды

By Acuity

Следующий отчет о доходах

5 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

726K

162M

Предыдущая цена открытия

-0.92

Предыдущая цена закрытия

1.35

Новостные настроения

By Acuity

28%

72%

40 / 339 Рейтинг в Healthcare

Codexis Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 сент. 2026 г., 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

17 сент. 2026 г., 20:01 UTC

Codexis Inc shares fell sharply, continuing a trend of three consecutive sessions lower, with the current price significantly below its 20-day moving average.

16 сент. 2026 г., 19:22 UTC

Codexis Inc shares fell sharply amid a broader market downturn, pressured by rising U.S. Treasury yields and inflation concerns following strong retail sales data.

15 сент. 2026 г., 20:01 UTC

Codexis Inc shares are trading lower as the NY Empire State Manufacturing Index fell to 7.6 in September, raising concerns about economic contraction.

4 сент. 2026 г., 19:51 UTC

Codexis Inc shares are higher during Friday's session amid market volatility, reflecting a notable early-session gain despite recent declines and no specific news.

3 сент. 2026 г., 20:07 UTC

Codexis Inc shares are lower during Thursday's session, marking four consecutive days of declines amid broader market weakness and rising jobless claims.

1 сент. 2026 г., 20:01 UTC

Codexis Inc shares are lower amid broader market concerns over rising oil prices and inflation, with no specific news identified to explain the decline.

31 авг. 2026 г., 20:02 UTC

Codexis Inc is gaining during Monday's session, despite an earlier pullback. Broader market conditions reflect heightened expectations for potential interest rate hikes.

28 авг. 2026 г., 19:51 UTC

Codexis Inc. shares are trading lower today, having peaked earlier in the session before declining significantly. No specific news has been identified.

27 авг. 2026 г., 20:07 UTC

Codexis Inc. shares are trading roughly flat amid minimal market movement. The stock remains above its 20-day moving average and near its one-month range.

26 авг. 2026 г., 19:56 UTC

Codexis Inc. shares are lower today, reflecting a broader downward trend amid persistent inflationary pressures impacting market sentiment.

24 авг. 2026 г., 19:16 UTC

Codexis Inc. shares are trading higher during Monday's session, with market focus on upcoming macroeconomic developments, including a speech by Federal Reserve Chair Kevin Warsh.

21 авг. 2026 г., 19:46 UTC

Correlated Moves

Codexis Inc shares are higher today, reflecting strong momentum. This aligns with a broader biotechnology trend, supported by gains in the ARK Genomic Revolution ETF.

20 авг. 2026 г., 19:16 UTC

Codexis Inc. shares are roughly flat as no specific news emerged. Intraday fluctuations ranged from a high of 8.23% to a low of -1.27%.

19 авг. 2026 г., 20:02 UTC

Correlated Moves
News

Codexis Inc shares are higher today, supported by positive momentum in the genomics sector and the performance of the ARK Genomic Revolution ETF.

18 авг. 2026 г., 19:41 UTC

Codexis Inc shares are trading lower during Tuesday's session, continuing a decline since Monday's close amid broader market concerns over rising treasury yields and inflation.

17 авг. 2026 г., 19:56 UTC

News

Codexis shares are higher as Piper Sandler maintains Overweight rating and lowers price target to $8.00 from $9.00. Positive investor sentiment persists.

14 авг. 2026 г., 19:46 UTC

Codexis Inc shares are lower, reflecting broader market weakness amid an unexpected decline in U.S. retail sales for July.

13 авг. 2026 г., 19:51 UTC

News

Codexis reported Q2 2026 revenue of $14.9 million and a net loss of $12.0 million. Shares are trading roughly flat during Thursday's session.

12 авг. 2026 г., 20:01 UTC

News

Codexis reported a narrower net loss of $12 million and reaffirmed revenue guidance of $72 million to $76 million, contributing to gains during Wednesday's session.

11 авг. 2026 г., 23:51 UTC

News

Codexis reported second-quarter revenues of $14.9 million, exceeding estimates. Shares are trading higher in after-market hours following the positive earnings report and guidance.

10 авг. 2026 г., 19:21 UTC

News

Codexis Inc shares are higher following a positive earnings report, with a loss per share of -$0.10, better than analysts' expectations of -$0.11.

7 авг. 2026 г., 19:36 UTC

Codexis Inc shares are lower, reflecting broader market trends amid uncertainty over monetary policy and a weaker-than-expected jobs report.

6 авг. 2026 г., 19:56 UTC

Codexis Inc shares are higher during Thursday's session, continuing an upward trend. The stock remains below its 20-day moving average.

5 авг. 2026 г., 20:06 UTC

Codexis Inc shares are higher today, reflecting positive market sentiment amid a broader uptick in equities. No specific news was identified for the movement.

4 авг. 2026 г., 19:56 UTC

Codexis Inc. shares are trading roughly flat, with no specific news identified. The stock remains below its 20-day moving average and near its one-month range low.

3 авг. 2026 г., 19:44 UTC

News

Codexis Inc has appointed David Butler, PhD, to its Strategic Advisory Board. Shares are advancing, though still below the 20-day moving average.

31 июл. 2026 г., 20:02 UTC

Codexis Inc shares are trading lower today, continuing a broader decline. The stock is near the lower end of its one-month range.

30 июл. 2026 г., 20:09 UTC

Codexis Inc shares are higher today, continuing their rise since Wednesday's close. Broader market volatility is influenced by mixed economic signals.

29 июл. 2026 г., 19:47 UTC

Macro Event

Codexis Inc shares are lower amid broader market declines and heightened volatility following the Federal Reserve's decision to keep interest rates steady.

Сравнение c конкурентами

Изменение цены

Codexis Inc Прогноз

Целевая цена

By TipRanks

430.3% рост

Прогноз на 12 месяцев

Средняя 7 USD  430.3%

Максимум 11 USD

Минимум 2 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Codexis Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

3

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

40 / 339Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.